S. Korea approves Novavax COVID-19 vaccine

SEOUL-- South Korea's drug safety agency on Wednesday authorized the use of U.S.-based biotechnology company Novavax Inc.'s COVID-19 vaccine.The protein-based vaccine, Nuvaxovid, marks the fifth COVID-19 vaccine to get approval…